1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "40045-50-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-107597
    SU3327

    JNK Metabolic Disease Inflammation/Immunology
    SU3327 is a potent, selective and substrate-competitive JNK inhibitor with an IC50 of 0.7 μM. SU3327 also inhibits protein-protein interactions between JNK and JNK Interacting Protein (JIP) with an IC50 of 239 nM. SU3327 shows less active against p38α and Akt kinase.